Infliximab for the treatment of refractory immune-related hepatitis secondary to checkpoint inhibitors: A case report

Infliximab for the treatment of refractory immune-related hepatitis secondary to checkpoint inhibitors: A case report

Bibliographic Details
Main Authors: Margaret Corrigan, Geoffrey Haydon, Fiona Thompson, Neil Rajoriya, Claire L Peplow, Stefan G Hubscher, Neil Steven, Gideon M Hirschfield, Matthew J Armstrong
Format: Article
Language:English
Published: Elsevier 2019-05-01
Series:JHEP Reports
Subjects:
Hepatitis
Immunotherapy
Infliximab
checkpoint
Online Access:http://www.sciencedirect.com/science/article/pii/S2589555919300084

Internet

http://www.sciencedirect.com/science/article/pii/S2589555919300084

Similar Items